Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Overview Zen Score Price Valuation Financials

Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
IFRX	INFLARX NV	$78.31M	-40.30%	-36.40%	-41.24%	-45.40%	0.17	6.50	-743.70%	-67,630.70%	-67,574.22%
IMTX	IMMATICS NV	$847.42M	-43.50%	-22.30%	-27.44%	-52.40%	1.27	2.87	100.00%	-179.60%	-179.63%
QSI	QUANTUM-SI INC	$233.92M	-31.50%	-29.00%	-33.48%	-40.70%	0.10	22.94	45.10%	-8,868.80%	-8,868.76%
VRDN	VIRIDIAN THERAPEUTICS INC	$808.45M	-68.30%	-61.10%	-50.86%	-85.10%	0.11	18.27	100.00%	-75,711.50%	-75,123.25%
STTK	SHATTUCK LABS INC	$502.76M	-63.10%	-56.10%	-58.94%	-125.10%	0.10	12.51	100.00%	-5,268.40%	-5,268.44%
APRE	APREA THERAPEUTICS INC	$28.24M	-65.60%	-52.40%	-84.92%	463.90%	0.34	5.14	100.00%	-2,449.60%	-2,659.48%
SAGE	SAGE THERAPEUTICS INC	$823.89M	-60.90%	-54.70%	-71.29%	-71.60%	0.09	12.22	96.50%	-552.50%	-552.52%
VCYT	VERACYTE INC	$1.45B	-7.00%	-6.50%	-7.27%	-124.00%	0.07	4.66	68.70%	-20.60%	-21.22%
CRNX	CRINETICS PHARMACEUTICALS INC	$2.93B	-52.90%	-45.50%	-36.27%	-54.80%	0.18	13.07	100.00%	-5,345.90%	-5,345.85%
BLUE	BLUEBIRD BIO INC	$100.92M	-34.30%	-14.40%	-21.88%	-16.50%	1.76	1.55	-10.10%	-419.60%	-457.81%
LSTA	LISATA THERAPEUTICS INC	$22.00M	-37.90%	-34.50%	-48.17%	-82.70%	0.14	8.18	N/A	N/A	N/A
HOTH	HOTH THERAPEUTICS INC	$5.11M	-76.30%	-66.80%	-88.73%	786.70%	0.08	13.89	N/A	N/A	N/A
ARVN	ARVINAS INC	$2.20B	-70.20%	-31.80%	-34.98%	-52.20%	0.98	4.98	100.00%	-467.90%	-466.75%
LQDA	LIQUIDIA CORP	$952.63M	-132.20%	-65.40%	-72.39%	-129.20%	1.50	4.85	83.50%	-448.90%	-413.02%
CASI	CASI PHARMACEUTICALS INC	$32.38M	-86.40%	-34.20%	-46.15%	-52.40%	2.12	3.55	59.20%	-79.60%	-79.75%
MTEM	MOLECULAR TEMPLATES INC	$9.16M	-7,646.10%	-16.80%	-30.35%	-20.70%	7.40	0.97	100.00%	-14.20%	-9.56%
MESO	MESOBLAST LTD	$633.23M	-14.50%	-10.90%	-8.37%	-57.30%	0.32	2.72	100.00%	-1,007.30%	-737.49%
CRBU	CARIBOU BIOSCIENCES INC	$335.07M	-31.10%	-25.70%	-25.22%	-31.20%	0.17	11.97	100.00%	-296.10%	-295.49%
BEAM	BEAM THERAPEUTICS INC	$1.75B	-15.90%	-9.80%	-10.46%	-12.60%	0.49	5.89	100.00%	-35.10%	-34.73%
GLMD	GALMED PHARMACEUTICALS LTD	$1.98M	-53.30%	-44.40%	-53.98%	-67.40%	0.20	4.81	N/A	N/A	N/A
AUPH	AURINIA PHARMACEUTICALS INC	$710.07M	-20.10%	-14.80%	-15.86%	-16.10%	0.45	5.50	91.90%	-44.50%	-42.56%
YMAB	Y-MABS THERAPEUTICS INC	$643.96M	-20.70%	-16.30%	-23.83%	-123.00%	0.27	5.52	86.50%	-25.30%	-30.27%
MOLN	MOLECULAR PARTNERS AG	$127.47M	-31.00%	-27.80%	-30.90%	-39.60%	0.12	13.35	100.00%	-880.70%	-807.46%
ATAI	ATAI LIFE SCIENCES NV	$320.43M	-16.80%	-14.20%	-13.37%	-21.50%	0.20	9.22	100.00%	-12,810.20%	-11,640.76%
ABSI	ABSCI CORP	$516.55M	-52.50%	-44.10%	-58.30%	-92.90%	0.23	4.08	100.00%	-1,933.60%	-1,914.24%
IMNM	IMMUNOME INC	$819.60M	-286.40%	-129.00%	-84.29%	1,140.10%	0.24	6.63	100.00%	-761.90%	-761.92%
PLUR	PLURI INC	$27.78M	-209.50%	-49.60%	-60.17%	-32.80%	7.94	7.12	97.50%	-6,708.40%	-6,242.02%
XOMA	XOMA CORP	$295.41M	-44.20%	-30.00%	-18.74%	-41.50%	1.64	8.68	100.00%	-973.20%	-846.20%
LYEL	LYELL IMMUNOPHARMA INC	$551.39M	-32.70%	-28.80%	-32.79%	-36.10%	0.15	16.07	100.00%	-180,486.20%	-180,486.15%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$820.01M	-294.90%	-78.60%	-77.81%	-58.10%	2.85	7.08	91.60%	-439.80%	-384.72%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$5.86M	-41.50%	-40.20%	-51.11%	-366.80%	0.04	27.66	60.00%	-58,739.70%	-58,739.71%
INO	INOVIO PHARMACEUTICALS INC	$247.02M	-86.60%	-62.60%	-104.29%	-81.80%	0.46	3.60	100.00%	-16,239.90%	-16,092.90%
SPRC	SCISPARC LTD	$1.45M	65.00%	47.00%	64.50%	245.90%	0.21	4.10	76.30%	177.90%	215.32%
MRNS	MARINUS PHARMACEUTICALS INC	$76.77M	-264.60%	-70.70%	-96.75%	-88.30%	9.19	4.07	93.80%	-456.30%	-406.75%
PRTC	PURETECH HEALTH PLC	$774.78M	-13.10%	-9.40%	-5.47%	-7.20%	0.51	6.76	100.00%	-1,972.90%	-1,056.22%
IKNA	IKENA ONCOLOGY INC	$62.74M	-44.20%	-37.30%	-38.41%	-75.20%	0.13	12.58	100.00%	-744.20%	-745.94%
KROS	KEROS THERAPEUTICS INC	$2.08B	-46.70%	-42.60%	-44.26%	-495.40%	0.11	14.25	100.00%	-101,319.20%	-101,319.21%
SWTX	SPRINGWORKS THERAPEUTICS INC	$3.36B	-65.70%	-57.00%	-50.20%	-81.00%	0.16	6.41	92.30%	-5,968.50%	-5,968.50%
NTLA	INTELLIA THERAPEUTICS INC	$2.00B	-43.90%	-36.40%	-40.58%	-42.80%	0.24	8.67	100.00%	-1,326.50%	-1,326.51%
GTHX	G1 THERAPEUTICS INC	$208.28M	-106.00%	-34.00%	-37.91%	-29.40%	2.44	3.87	91.30%	-58.10%	-42.19%
GLYC	GLYCOMIMETICS INC	$105.70M	-73.10%	-64.40%	-95.89%	1,860.30%	0.18	6.41	100.00%	-368,994.20%	-368,994.20%
ABCL	ABCELLERA BIOLOGICS INC	$1.10B	-12.40%	-9.70%	-12.71%	-15.70%	0.29	7.33	100.00%	-385.00%	-457.67%
PGEN	PRECIGEN INC	$350.98M	-62.20%	-48.50%	-74.88%	-113.20%	0.28	2.99	1.70%	-1,540.60%	-1,540.47%
CUE	CUE BIOPHARMA INC	$66.40M	-112.30%	-71.10%	-111.34%	-308.40%	0.66	3.01	100.00%	-924.10%	-901.42%
QTTB	Q32 BIO INC	$90.49M	-104.50%	-76.30%	-154.76%	-108.50%	0.16	7.25	100.00%	-9,771.70%	-9,771.71%
ALLO	ALLOGENE THERAPEUTICS INC	$488.68M	-56.70%	-45.60%	-54.03%	-52.30%	0.26	12.38	100.00%	-344,489.50%	-344,489.47%
CCCC	C4 THERAPEUTICS INC	$423.27M	-55.30%	-35.80%	-38.91%	-38.90%	0.53	6.34	100.00%	-638.30%	-625.55%
MIST	MILESTONE PHARMACEUTICALS INC	$81.85M	-171.00%	-64.40%	-84.02%	-55.30%	3.49	10.11	100.00%	-5,968.50%	-5,713.10%
SRPT	SAREPTA THERAPEUTICS INC	$12.09B	-69.70%	-17.10%	-19.92%	-15.80%	2.80	3.95	87.90%	-43.10%	-41.83%
TARS	TARSUS PHARMACEUTICALS INC	$1.10B	-74.30%	-58.20%	-57.99%	-164.60%	0.35	6.93	90.90%	-778.90%	-759.71%
DNLI	DENALI THERAPEUTICS INC	$2.15B	-13.50%	-11.40%	-13.49%	-13.70%	0.12	13.65	100.00%	-43.90%	-43.93%
LYRA	LYRA THERAPEUTICS INC	$281.99M	-74.10%	-51.90%	-50.91%	-77.40%	0.60	5.35	100.00%	-4,023.10%	-4,019.32%
ALEC	ALECTOR INC	$502.68M	-77.20%	-19.00%	-28.20%	-27.20%	3.64	3.18	100.00%	-134.30%	-128.97%
COCP	COCRYSTAL PHARMA INC	$15.82M	-56.90%	-52.10%	-61.95%	-927.20%	0.19	8.92	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$6.88M	-141.20%	-129.20%	-108.42%	3,531.00%	0.11	10.27	N/A	N/A	N/A
INVA	INNOVIVA INC	$964.85M	29.70%	15.40%	17.69%	18.60%	0.84	9.03	86.30%	57.90%	68.69%
ALPN	ALPINE IMMUNE SCIENCES INC	$4.23B	-15.50%	-11.30%	-9.47%	-14.80%	0.16	7.86	100.00%	-54.70%	-54.32%
MGNX	MACROGENICS INC	$909.01M	-5.80%	-2.80%	-3.15%	-3.80%	0.96	4.48	86.00%	-15.40%	-12.98%
OVID	OVID THERAPEUTICS INC	$219.20M	-49.80%	-38.20%	-39.49%	-55.10%	0.64	9.55	100.00%	-13,362.20%	-13,362.17%
LUMO	LUMOS PHARMA INC	$22.46M	-85.60%	-65.30%	-101.35%	-414.60%	0.49	5.70	100.00%	-1,659.40%	-1,660.80%
LXRX	LEXICON PHARMACEUTICALS INC	$389.05M	-139.70%	-71.90%	-82.89%	-73.50%	1.46	5.60	92.90%	-14,710.90%	-13,622.76%
PPBT	PURPLE BIOTECH LTD	$9.72M	49.00%	41.70%	59.47%	-707.20%	0.29	2.20	N/A	N/A	N/A
KYMR	KYMERA THERAPEUTICS INC	$2.04B	-34.80%	-25.30%	-29.95%	-28.60%	0.46	4.73	100.00%	-187.00%	-186.74%
SXTP	60 DEGREES PHARMACEUTICALS INC	$2.75M	N/A	-49.20%	-29.89%	-32.50%	0.61	2.55	-87.10%	-1,547.70%	-583.19%
QURE	UNIQURE NV	$216.71M	-99.30%	-37.70%	-34.96%	-32.80%	3.01	8.85	14.00%	-1,947.10%	-1,672.66%
NGNE	NEUROGENE INC	$385.08M	-34.40%	-28.80%	-18.19%	-53.10%	0.20	8.72	N/A	N/A	N/A
PALI	PALISADE BIO INC	$5.15M	-89.70%	-76.20%	-107.28%	-67,402.70%	0.24	5.15	100.00%	-4,926.40%	-4,920.40%
SLRN	ACELYRIN INC	$417.07M	-74.60%	-57.00%	-58.04%	-149.90%	0.13	8.65	N/A	N/A	N/A
GBIO	GENERATION BIO CO	$192.78M	-52.30%	-31.80%	-37.81%	-36.50%	0.85	6.83	100.00%	-2,144.50%	-2,144.51%
VIR	VIR BIOTECHNOLOGY INC	$1.11B	-34.90%	-27.70%	-36.02%	-42.70%	0.21	9.06	96.80%	-713.70%	-728.87%
CYCN	CYCLERION THERAPEUTICS INC	$7.94M	-63.30%	-42.00%	-49.80%	-600.10%	0.19	3.85	N/A	N/A	N/A
CABA	CABALETTA BIO INC	$531.14M	-40.80%	-37.90%	-28.48%	-171.20%	0.07	15.29	N/A	N/A	N/A
TVTX	TRAVERE THERAPEUTICS INC	$400.28M	-56.70%	-14.10%	-16.34%	-12.30%	2.93	3.47	92.10%	-76.70%	-68.74%
LABP	LANDOS BIOPHARMA INC	$69.53M	-54.90%	-49.10%	-69.00%	918.60%	0.20	6.09	N/A	N/A	N/A
IOBT	IO BIOTECH INC	$93.55M	-66.30%	-59.60%	-63.13%	3,838.80%	0.13	9.37	N/A	N/A	N/A
DMAC	DIAMEDICA THERAPEUTICS INC	$97.55M	-39.90%	-37.70%	-37.49%	-42.40%	0.06	19.27	N/A	N/A	N/A
RLAY	RELAY THERAPEUTICS INC	$835.61M	-42.40%	-36.50%	-42.03%	-43.80%	0.12	25.44	100.00%	-1,338.70%	-1,338.66%
RIGL	RIGEL PHARMACEUTICALS INC	$192.92M	N/A	-21.20%	-28.49%	-24.20%	-5.09	1.86	93.90%	-21.50%	-15.59%
CRDF	CARDIFF ONCOLOGY INC	$181.84M	-50.20%	-44.30%	-58.21%	-60.20%	0.17	7.42	100.00%	-8,496.90%	-8,492.01%
PMCB	PHARMACYTE BIOTECH INC	$17.86M	-25.10%	-15.20%	-1.79%	150.70%	0.72	8.16	N/A	N/A	N/A
TERN	TERNS PHARMACEUTICALS INC	$317.44M	-33.50%	-31.90%	-35.07%	-51.30%	0.05	22.39	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$191.71M	-31.50%	-28.90%	-34.35%	-37.90%	0.08	15.03	N/A	N/A	N/A
ATXS	ASTRIA THERAPEUTICS INC	$494.13M	-34.70%	-33.40%	-29.98%	-138.70%	0.05	21.73	N/A	N/A	N/A
TTNP	TITAN PHARMACEUTICALS INC	$6.48M	-165.90%	-105.70%	-83.85%	1,677.40%	0.22	5.55	100.00%	-3,026.60%	-3,026.63%
AVXL	ANAVEX LIFE SCIENCES CORP	$282.47M	-30.30%	-27.90%	-31.75%	510.50%	0.09	11.85	N/A	N/A	N/A
BPMC	BLUEPRINT MEDICINES CORP	$5.69B	-191.60%	-45.30%	-58.40%	-43.60%	7.03	3.76	94.90%	-203.30%	-195.37%
HOWL	WEREWOLF THERAPEUTICS INC	$288.48M	-32.20%	-20.40%	-22.02%	-49.00%	0.57	7.14	100.00%	-187.40%	-171.63%
FDMT	4D MOLECULAR THERAPEUTICS INC	$1.16B	-34.10%	-31.10%	-31.42%	-88.20%	0.10	15.65	100.00%	-486.60%	-486.59%
DTIL	PRECISION BIOSCIENCES INC	$64.87M	-200.80%	-34.50%	-53.82%	-2,413.80%	7.47	2.73	100.00%	-125.80%	-121.27%
ELVN	ENLIVEN THERAPEUTICS INC	$710.35M	-26.60%	-25.20%	-29.10%	-58.80%	0.11	10.28	N/A	N/A	N/A
DNA	GINKGO BIOWORKS HOLDINGS INC	$1.85B	-65.40%	-42.50%	-59.46%	-84.50%	0.52	6.11	78.50%	-355.10%	-355.07%
LRMR	LARIMAR THERAPEUTICS INC	$410.87M	-38.80%	-34.30%	-42.75%	-102.80%	0.17	9.49	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$630.96M	-34.90%	-32.60%	-25.65%	-174.30%	0.06	18.43	100.00%	-1,541.20%	-1,541.22%
SNSE	SENSEI BIOTHERAPEUTICS INC	$25.57M	-44.00%	-38.60%	-49.41%	-43.30%	0.15	11.92	N/A	N/A	N/A
ATOS	ATOSSA THERAPEUTICS INC	$191.72M	-29.50%	-28.50%	-33.06%	-567.50%	0.06	17.61	N/A	N/A	N/A
TBPH	THERAVANCE BIOPHARMA INC	$439.26M	-19.90%	-12.40%	-13.13%	-12.70%	0.79	5.39	100.00%	-96.10%	-81.71%
NTBL	NOTABLE LABS LTD	$8.70M	-61.50%	-47.90%	-66.38%	695.20%	0.29	5.65	36.50%	-3,598.10%	-3,598.06%
ETNB	89BIO INC	$772.32M	-31.00%	-27.80%	-23.56%	-61.00%	0.11	20.04	N/A	N/A	N/A
AKRO	AKERO THERAPEUTICS INC	$1.11B	-29.70%	-27.20%	-26.49%	-57.20%	0.08	29.27	N/A	N/A	N/A
ABIO	ARCA BIOPHARMA INC	$51.94M	-16.10%	-15.50%	-17.09%	1,869.80%	0.05	23.19	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.72% over the past year, underperforming other biotech stocks by -8 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.53% from Incyte's current stock price of $51.68.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -7.45% over the past year, overperforming other biotech stocks by 15 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.33% from Harmony Biosciences Holdings's current stock price of $29.32.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock return 2.42% over the past year, overperforming other biotech stocks by 25 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 169.03% from Voyager Therapeutics's current stock price of $7.62.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 15.1%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.38%, which is 42 percentage points higher than the biotech industry average of 15.1%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)

Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.08%, which is -14 percentage points lower than the biotech industry average of 15.1%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.2% in the last day, and up 1.13% over the last week. Biodexa Pharmaceuticals was the among the top gainers in the biotechnology industry, gaining 79.31% yesterday.

Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has gained 2.42% in the past year. It has overperformed other stocks in the biotech industry by 25 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -20.21% in the past year. It has overperformed other stocks in the biotech industry by 2 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -29.72% in the past year. It has underperformed other stocks in the biotech industry by -8 percentage points.

Are biotech stocks a good buy now?

49.23% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 91.76% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 14.88x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.